Contact Us

Our Solutions

Marwood Group is a leading global healthcare advisory firm that provides diligence services and value creation to corporations and investors across provider, payor, HIT, life sciences and broader healthcare services.
Marwood provides in-depth perspectives focused on policy, market strategy, reimbursement, compliance, big data analytics and operations by leveraging its seasoned professionals each with 20+ years of healthcare experience, proprietary data capabilities and extensive stakeholder reach.
The Marwood Group is a healthcare-focused advisory and consulting firm headquartered in New York City with offices in Washington, D.C. and London.
Contact Us

We Serve a Broad Range of Clients

Healthcare Companies
Private Equity & Financial Sponsors
Asset Managers & Institutional Investors
Specialty & Commercial Lenders
Contact Us

Latest Insights


Pre-Recess Legislative & Regulatory Update | July 2024
Our experts Mark Galay, Stephen Williams, Kim Vukhac, and Joe Mercer discuss recent legislative & regulatory catalysts, including Congressional priorities entering August recess and setting up for the lame-duck session as well as the recently proposed Calendar Year 2025 rules

Watch Now
Medicaid Access Rule Review—HCBS Payment Adequacy; Next Steps for Stakeholders, Implementation; Outlook for Litigation
On April 22, HHS released the anticipated Ensuring Access to Medicaid Services final rule. In addition to Marwood’s forthcoming published analysis, Joe Mercer will host a call to offer takeaways from the rule and read-through for states and providers—especially around the HCBS payment adequacy standard, a provision that was highly contested by stakeholders throughout the rulemaking process.
April 23, 2024
1 p.m. ET
Key Takeaways
Medicare Advantage 2025 Final Rate Announcement Review
On April 1, HHS released the awaited Medicare Advantage and Part D Final Announcement. Our managed care and health care services senior analyst, Joe Mercer, hosted a call to offer takeaways from the rule, including the impacts of fourth quarter data, IME/DGME phase-out, and changes to the FFS normalization factor calculation, among other key provisions.
Tuesday, April 2, 2024
2 p.m. ET
Key Takeaways
Inpatient Psych Outlook—PPS Reform, Mental Health Parity, Telehealth, EHR Compliance
This year, CMS will be working on reforms to the inpatient psych prospective payment system. Looking ahead to the forthcoming FY 2025 proposed rule, Marwood hosted a call with Shawn Coughlin, President and CEO of the National Association for Behavioral Healthcare, to discuss broader industry priorities for the sector.
Tuesday, March 19, 2024
11 ET
Key Takeaways
Inpatient Rehab Outlook with AMRPA: Review Choice Demo Roll-Out, Landscape for MA Utilization, Case Mix Calculations, Early Discharge Penalty
Marwood hosted a call with Kate Beller, EVP of Policy Development and Government Relations at the American Medical Rehabilitation Providers Association, to discuss the forthcoming 2025 proposed rule and broader industry priorities.
February 22, 2024
11 ET
Key Takeaways

Our Commitment to ESG Values

Marwood is committed to environmental, social and governance values with the goal of creating and delivering sustained outcomes for our colleagues, clients, stakeholders, and community through holistic healthcare expertise and solutions


We educate stakeholders and enable the growth of sustainable companies by providing nuanced insights and analysis on the healthcare investment landscape.


We seek to implement meaningful and impactful initiatives in our surrounding communities, including charitable efforts to key industry and professional organizations.


Our comprehensive Compliance program addresses all aspects of our business. Proper governance is crucial to achieving our long-term goals and to best serve our clients, employees, and stakeholders.